Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblasts

被引:17
作者
Abe, Kazuki
Aslam, Akhmed
Walls, Andrew F.
Sato, Toshitsugu
Inoue, Hideo
机构
[1] Minophagen Pharmaceut Co, Pharmacol Res Dept, Kanagawa 2280002, Japan
[2] Univ Southampton, Southampton Gen Hosp, Immunopharmacol Grp, Southampton SO16 6YD, Hants, England
基金
英国医学研究理事会;
关键词
basic fibroblast growth factor; interleukin-1; beta; synovial fibroblasts; protease-activated receptors; PAR-2 agonist peptide; rheumatoid arthritis; tumor necrosis factor-alpha;
D O I
10.1016/j.lfs.2006.03.034
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Protease-activated receptors (PARs) have been implicated in the development of acute and chronic inflammatory responses. We have examined the expression of mRNA for PARs and their regulation by growth factors and cytokines in synovial fibroblasts derived from patients with rheumatoid arthritis (RA). Messenger RNA for PAR-1, -2 and -3 was detected in these cells, but not that for PAR-4. Expression of mRNA for PAR-2 was up-regulated by bFGF in a concentration-dependent manner, whereas expression of mRNA for PAR-1 and PAR-3 was not affected. Levels of mRNA encoding PAR-1, PAR-2 and PAR-3 did not increase in response to IL-1 beta and TNF-alpha. Expression of mRNA for PAR-2 was maximal 12 h after addition of bFGF, and maximal levels of immunoreactive PAR-2 were reached after 24 h. Furthermore, PAR-2 agonist peptide (SLIGKV-NH2), but not the inactive reverse peptide (VKGILS-NH2), induced transitory cytosolic Ca2+ mobilization in cells, and its response was increased by pretreatment with bFGF. An important role could be played by bFGF in the regulation of functional PAR-2 expression in cultured RA synovial fibroblasts. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:898 / 904
页数:7
相关论文
共 33 条
[21]  
Macfarlane SR, 2001, PHARMACOL REV, V53, P245
[22]   Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients [J].
Manabe, N ;
Oda, H ;
Nakamura, K ;
Kuga, Y ;
Uchida, S ;
Kawaguchi, H .
RHEUMATOLOGY, 1999, 38 (08) :714-720
[23]   Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2 [J].
Miike, S ;
McWilliam, AS ;
Kita, H .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6615-6622
[24]   Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue [J].
Morris, R ;
Winyard, PG ;
Brass, LF ;
Blake, DR ;
Morris, CJ .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (11) :841-843
[25]   THROMBIN IN INFLAMMATION AND HEALING - RELEVANCE TO RHEUMATOID-ARTHRITIS [J].
MORRIS, R ;
WINYARD, PG ;
BLAKE, DR ;
MORRIS, CJ .
ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (01) :72-79
[26]  
Nakano S, 1999, CLIN EXP RHEUMATOL, V17, P161
[27]   The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells - Comparison with the thrombin receptor [J].
Nystedt, S ;
Ramakrishnan, V ;
Sundelin, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (25) :14910-14915
[28]   Protease-activated receptors: Contribution to physiology and disease [J].
Ossovskaya, VS ;
Bunnett, NW .
PHYSIOLOGICAL REVIEWS, 2004, 84 (02) :579-621
[29]  
PERNOW B, 1985, J IMMUNOL, V135, pS812
[30]   Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation [J].
Pillinger, MH ;
Rosenthal, PB ;
Tolani, SN ;
Apsel, B ;
Dinsell, V ;
Greenberg, J ;
Chan, ESL ;
Gomez, PF ;
Abramson, SB .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :6080-6089